Vildabright-M

VILDABRIGHT-M

VILDABRIGHT-M Tablet is a combination medicine containing Vildagliptin and Metformin, used in the treatment of Type 2 diabetes mellitus.

This dual-action therapy works by improving insulin secretion, reducing glucose production in the liver, and enhancing insulin sensitivity, helping maintain stable blood sugar levels.

Uses of Vildabright-M Tablet

• Management of Type 2 diabetes mellitus
• Improves glycemic control
• Reduces risk of diabetes-related complications
• Supports metabolic and cardiovascular health

Key Benefits of Vildabright-M

• Dual mechanism for better blood sugar control
• Enhances insulin effectiveness
• Helps reduce insulin resistance
• Supports long-term diabetes management

Dosage & Administration

Vildabright-M should be taken as prescribed by your doctor, usually once or twice daily with meals to reduce gastrointestinal discomfort.

Contraindications

• Type 1 diabetes mellitus
• Severe kidney or liver disease
• Metabolic acidosis
• Allergy to Vildagliptin or Metformin

Possible Side Effects

• Nausea or stomach upset
• Diarrhea
• Headache
• Dizziness

If side effects persist, consult your doctor immediately.

Safety Advice

Monitor blood sugar regularly. Maintain a balanced diet and regular exercise routine. Follow medical advice strictly for best results.